US Universities Contributed to 87 Percent of Academic Patents Supporting FDA-Approved Drugs from 2020 to 2024

A recent analysis has revealed that U.S. universities played a significant role in the development of FDA-approved drugs between 2020 and 2024. During this period, patents originating from academic institutions underpinned half of all medications approved by the Food and Drug Administration (FDA). Among these contributions, 87% were traced back to American universities.

The findings highlight the substantial impact of academic research on pharmaceutical innovation during the four-year span. Researchers examined data from patents associated with FDA-approved drugs listed in the agency’s Orange Book, which catalogs drug products approved for safety and efficacy. The study identified that universities were responsible for key intellectual property supporting half of these approvals, underscoring their critical role in advancing medical treatments. Furthermore, U.S.-based institutions accounted for the vast majority—87%—of these academic contributions, demonstrating their prominence in global pharmaceutical research efforts during this time frame.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: June 6, 2025

Author

Mark Chiang